PHARMACEUTICAL COMPOSITIONS COMPRISING AZD0780

AR135174A1Pending Publication Date: 2026-07-08ASTRAZENECA AB
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ARP20250100305
Authority / Receiving Office
AR · AR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-02
Filing Date
2025-02-05
Publication Date
2026-07-08
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.

Claims

A pharmaceutical composition comprising: (a) from approximately 1 to approximately 25% by weight of AZD0780; (b) from approximately 60 to approximately 95% by weight of two or more pharmaceutical diluents; (c) from approximately 3 to approximately 5% by weight of one or more pharmaceutical disintegrants; (d) from approximately 0.5 to approximately 3% by weight of one or more pharmaceutical lubricants; (e) from 0.0 to approximately 5% by weight of one or more pharmaceutical sliders; and (f) from 0.0 to approximately 5% by weight of one or more pharmaceutical binders, wherein the weights of the components sum to 100, and a method for reducing LDL-C levels, reducing cardiovascular risk, and / or treating cardiovascular disease, comprising administering AZD0780, or a pharmaceutically acceptable salt thereof, to a subject in need at a daily dose of 1 mg to 30 mg.